Streptococcus pneumoniae, the aetiological agent of pneumonia and non-gonococcal urethritis, shares a high degree of DNA sequence identity with the viridans group of streptococci, particularly Streptococcus mitis and Streptococcus oralis. Although their clinical and pathological manifestations are different, discrimination between S. pneumoniae and its close viridans cocci relatives is still quite difficult. Suppression subtractive hybridization was performed to identify the genomic differences between S. pneumoniae and S. mitis. Thirty-four resulting S. pneumoniaespecific clones were examined by sequence determination and comparative DNA sequence analysis using BLAST. S. pneumoniae-specific primers were subsequently designed from one of the clonal DNA sequences containing the cps gene (coding for capsular polysaccharide biosynthesis). The primer specificities were evaluated using 49 viridans streptococci including 26 S. pneumoniae, 54 other streptococci, 14 Lactococcus species, 14 Enterococcus species and three Vagococcus species, and compared with the specificities of previously described autolysin (lytA), pneumolysin (ply), Spn9802 and Spn9828 primers. The newly designed cpsA-specific primer set was highly specific to S. pneumoniae and was even better than the existing primers. These findings may help improve the rapid identification and differentiation of S. pneumoniae from closely related members of the viridans group streptococci.
INTRODUCTION
Streptococcus pneumoniae is an important pathogen associated with various human diseases such as pneumonia, non-gonococcal urethritis, otitis media, septicaemia and meningitis (Whatmore et al., 2000) . In contrast, two viridans group streptococci, Streptococcus oralis and Streptococcus mitis, cause dental caries and endocarditis and are usually considered commensal microorganisms of the oral cavity (Dyson et al., 1999; Willcox et al., 1988) . Because S. pneumoniae is often isolated with S. mitis and S. oralis, accurate discrimination between these strains is important for proper diagnosis and treatment of S. pneumoniae.
In recent years, molecular genetic analyses based on the 16S rRNA gene have provided a potent means of characterization at the species level (Fox et al., 1992; Stackebrandt et al., 1991; Stackebrandt & Goebel, 1994) . Unfortunately, S. pneumoniae shares over 99 % 16S rRNA gene identity with S. mitis and S. oralis (Suzuki et al., 2005) , complicating molecular identification among them. Several molecular assays have been developed to identify S. pneumoniae from the other viridans group streptococci using primers specific to pneumococcal virulence factors such as genes encoding pneumolysin (ply) (Corless et al., 2001) , autolysin (lytA) (McAvin et al., 2001) , pneumococcal surface antigen A (Morrison et al., 2000) , manganese-dependent superoxide dismutase (Kawamura et al., 1999) and penicillin-binding protein (O'Neill et al., 1999) .
Recently, real-time PCR methods have improved the detection of these organisms (Abdeldaim et al., 2008; Carvalho et al., 2007; Corless et al., 2001; Suzuki et al., 2006) . At the same time, increasing evidence suggests the possible occurrence of lateral gene transfer among the naturally transformable viridans group streptococci. Indeed, some pneumococcal virulence genes of S. pneumoniae have occasionally been detected in S. mitis or S. oralis isolates Verhelst et al., 2003; Whatmore et al., 2000) .
Previously, two genomic clones specific to S. pneumoniae, referred as to Spn9802 and Spn9828, were identified by genomic subtractive hybridization (Suzuki et al., 2005) . A few false-positive results were reported, however, from samples where S. pneumoniae was not isolated (Abdeldaim et al., 2008; Suzuki et al., 2006) . Suppression subtractive hybridization (SSH) is a powerful tool for searching for genomic differences among closely related strains (Kim et al., 2008) or for identifying novel virulence factors by genomic comparison of pathogenic and non-pathogenic strains (Agron et al., 2002) . In this study, SSH was used to identify novel genomic markers specific to S. pneumoniae, allowing accurate discrimination of S. pneumoniae from members of the closely related viridans group streptococci.
METHODS
Bacterial strains. A total of 134 bacterial strains were used in this study (Table 1) . The 26 S. pneumoniae strains were obtained from the Korean Collection for Type Cultures (KCTC; Daejeon, Korea), the Culture Collection of Antibiotic-resistant Microbes (CCARM; Seoul, Korea) and the Department of Oral Biochemistry, College of Dentistry, Chosun University (ChDC; Gwangju, Korea). The remaining 108 reference Streptococcus strains were obtained from the Culture Collection of the University of Gothenburg (CCUG; Gothenburg, Sweden), the American Type Culture Collection (ATCC; Manassas, VA, USA), the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ; Braunschweig, Germany), the Belgian Coordinated Collections of Micro-organisms (BCCM/LMG; Gent, Belgium), the ChDC or the KCTC.
Genomic DNA preparation. Each bacterial strain was grown on either 5 % sheep blood agar (Difco) for oral streptococci strains or brain-heart infusion agar (Difco) for the other strains at 37 uC for 20 h. Genomic DNA was extracted from 1.4 ml bacterial culture using a cetyltrimethylammonium bromide method (Ausubel et al., 1993) . Purified DNA was dissolved in sterile water with 40 mg RNase A ml 21 and quantified using an Infinite 200 NanoQuant (Tecan) at a wavelength of 260 nm.
Construction of the SSH library. SSH was performed with S. pneumoniae KCTC 5080 T as the tester genomic DNA and the most closely related Streptococcus species, S. mitis KCTC 3556 T , as the driver genomic DNA. The SSH library was generated using a PCR-Select Bacterial Genome Subtraction kit (Clontech) as described previously (Akopyants et al., 1998) . Briefly, both tester and driver genomic DNAs were digested with the restriction enzyme RsaI (New England Biolabs) at 37 uC for 2 h to obtain DNA fragments smaller than 3.0 kb. Two different adaptors were separately ligated to the 59 end of the restricted tester DNA fragments: one with adaptor 1 (59-CTAATACGACTC-ACTATAGGGCTCGAGCGGCCGCCCGGGCAGGT-39 and 39-GGC-CCGTCCA-59) and the other with adaptor 2R (59-CTAATACGACT-CACTATAGGGCAGCGTGGTCGCGGCCGAGGT-39 and 39-GCCG-GCTCCA-59). Two hybridizations were performed. In the first hybridization, the restricted driver DNA fragments were added to each adaptor-linked tester DNA fragment (ratio 4 : 1). The resultant two driver/adaptor DNA mixtures were denatured at 98 uC for 1.5 min, annealed at 42 uC for 1.5 h and then mixed together before the second hybridization. Five hundred nanograms of the driver genomic DNA was added to the combined DNA mixture before the second hybridization, which was carried out at 42 uC for 16 h. Using the adaptor-specific primer (59-CTAATACGACTCACTATAGGGC-39), the tester-specific DNA fragments were amplified by two sequential nested PCRs, as only the unhybridized tester DNA sequences should reassociate to form double-stranded tester DNA fragments ligated to two different adaptors. The resultant PCR products were ligated into the pCR2.1-TOPO vector system (Invitrogen) and transformed into One Shot TOP10 E. coli strains (Invitrogen). The transformants were plated onto Luria-Bertani medium containing ampicillin/IPTG/X-Gal and white colonies were screened for the insert fragment. Colony PCR with the nested primers 1 (59-TCGAGCGGCCGCCCGGGCAGGT-39) and 2R (59-AGCGTGGTCGCGGCCGAGGT-39) was used to confirm the presence of the insert DNA fragments by agarose gel electrophoresis.
Reverse Southern dot-blot analysis. All putative clones were subjected to differential dot-blot analysis to verify whether they were specific for the tester genomic DNA. Briefly, 25 ml of equal amounts of each DNA sample were dotted in duplicate onto positively charged Hybond-N + nylon membranes (Amersham Biosciences). DNA samples were exposed to 1000 mJ UV for 3.5 min in a Stratalinker (Stratagene). DNA probes were prepared with the RsaI-digested genomic DNA of each strain (S. pneumoniae KCTC 5080 T and S. mitis KCTC 3556 T ) using an ECL Direct Nucleic Acid Labelling and Detection System (Amersham Biosciences). The probe was used for each of the duplicate membranes. Pre-hybridization and hybridization were carried out according to the manufacturer's instructions (Amersham Biosciences). The membrane was exposed to Hyperfilm ECL (Amersham Biosciences) for visualization.
DNA sequencing and analysis. Each clone was sequenced in duplicate with M13 forward (220) and/or reverse primers using a BigDye Terminator Cycle Sequencing kit and an ABI PRISM 3100 automated DNA sequencer (Applied Biosystems). Sequence assembly and further editing were performed with CLUSTAL_X (Thompson et al., 1997) . The nucleotide sequence identities of the genomic subtracted fragments of S. pneumoniae KCTC 5080 T were determined using the BLASTX program available on the BLAST network service of the National Center for Biotechnology Information.
Design of PCR primers and PCR conditions. Oligonucleotide primer sets specific to S. pneumoniae were designed using Primer3 software (Rozen & Skaletsky, 2000) based on a 492 bp sequence of the cpsA gene from one of the SSH clones. The reaction conditions were optimized using a TGradient Thermal Cycler (Biometra). The lytA, ply, Spn9828 and Spn9802 primers were evaluated to compare PCR specificity, as described previously (Suzuki et al., 2005) . The PCR was performed with 100 ng genomic DNA as a template in a 20 ml reaction mixture that contained 1 ml each primer, 2 ml 106 PCR buffer, 1 ml 10 mM dNTPs and 0.3 ml Taq DNA polymerase. PCR amplification was carried out using a GeneAmp PCR system 2700 (Applied Biosystems) with the following conditions: for ply, Spn9802 and Spn9828 primers, initial denaturation at 94 uC for 2 min and 25 cycles of 94 uC for 10 s, 58 uC for 15 s and 72 uC for 1 min, followed by a final extension at 72 uC for 5 min; for lytA primers, initial denaturation at 94 uC for 2 min and 30 cycles of 94 uC for 15 s, 53 uC for 15 s and 72 uC for 15 s, with a final extension at 72 uC for 5 min; for cpsA primers, initial denaturation at 94 uC for 5 min and 30 cycles of 94 uC for 30 s, 58 uC for 30 s and 72 uC for 40 s, followed by a final extension at 72 uC for 10 min. The PCR products were analysed in 1.2 % Seakem LE agarose gels (FMC Bioproducts) and visualized by ethidium bromide staining. 
Identification and annotation of S. pneumoniaespecific clones
The identity of the 34 S. pneumoniae-specific clones was examined using BLAST homology searches. The resultant data revealed sequences highly homologous to the genomic DNA sequences of S. pneumoniae available in GenBank, including four transporter proteins, 10 hypothetical proteins, 14 metabolism proteins, one membrane protein and five miscellaneous proteins.
Among those tested, a single clone possessed the 492 nt sequence specific to S. pneumoniae that corresponded to a partial region of the capsular polysaccharide biosynthesis (cps) gene. Previously, pneumococcal capsular polysaccharide was determined to be an essential virulence factor of S. pneumoniae with anti-phagocytic activity. However, capsule expression can also reduce bacterial attachment to respiratory epithelial cells and inhibit bacterial colonization (Adamou et al., 1998; Cundell et al., 1995; Weiser et al., 1994) . Supporting this notion, recent electron microscopy imaging has demonstrated that S. pneumoniae cells that are intimately adherent to epithelial cells have thin capsule layers, indicating downregulation of capsule expression to enhance bacterial adherence (Hammerschmidt et al., 2005) . The chromosomal location of the cps operon has been localized between the dexB and aliA genes (García & Ló pez, 1997; Guidolin et al., 1994; Morona et al., 1997; Munoz et al., 1997) . Although the first four genes (cpsABCD) of the cps operon are commonly present (García et al., 1999; Jiang et al., 2001) , it is known that pneumococcal capsules are structurally distinct among the different serotypes of S. pneumoniae (Austrian, 1981; Henrichsen, 1995) .
Diagnostic screening of the cpsA gene as a novel S. pneumoniae-specific marker To identify genomic markers unique for S. pneumoniae, primer sets were designed for the cpsA gene (GenBank accession no. NC_011072) ( Table 2) , and their specificity for S. pneumoniae was evaluated with a total of 134 reference strains, including 26 S. pneumoniae, two Streptococcus pseudopneumoniae and 106 other related cocci, by gradient PCR assay. The PCR results are summarized in Table 3 . One of the cpsA-specific primer sets (cpsA-382F and cpsA-735R) was highly specific to S. pneumoniae with the expected PCR product of 353 bp, and did not amplify any other reference strain (Fig. 1) .
The lytA, ply, Spn9802 and Spn9828 primers (Table 2) have been used previously for S. pneumoniae screening. Because some of the related oral streptococci can harbour the S. pneumoniae lytA and ply genes due to horizontal gene transfer , a PCR method with Spn9802-and Spn9828-specific primers, in combination with lytA-and ply-specific primers, has proved useful for identifying S. pneumoniae. Although both the Spn9802 and Spn9828 genes encode proteins of unknown function, they are known to be specific to S. pneumoniae. Accordingly, both the specificity and efficiency of the cpsA-specific primers were compared with those of the primer sets for lytA, ply, Spn9802 and Spn9828 (Suzuki et al., 2005) . Notably, a few false-positive amplifications with the ply, Spn9802 and Spn9828 primer sets were observed from the genomic DNAs of S. mitis (1/17 strains), S. pseudopneumoniae (2/2 strains), Streptococcus Table 3 . PCR screening using the primer sets specific for S. pneumoniae
Strains: 1, S. pneumoniae; 2, S. mitis; 3, S. oralis; 4, S. pseudopneumoniae; 5, S. pyogenes; 6, S. gordonii; 7, S. sanguinis; 8, S. parasanguinis; 9, S. constellatus; 10, S. intermedius; 11, S. anginosus; 12, Lactococcus spp.; 13, Enterococcus spp.; 14, Vagococcus spp. +, Positive; 2, negative.
Primer set
Result for atypical cocci strains Fig. 1 . Electrophoretic examination of S. pneumoniae-specific PCR products generated with primers cpsA-382F and cpsA-735R based on the cpsA gene. Lanes: M, GeneRuler 1 kb DNA ladder (Fermentas); 1, S. pneumoniae KCTC 5080 T ; 2, S. pneumoniae CCARM 4009; 3, S. pneumoniae CCARM 4019; 4, S. pneumoniae CCARM 4033; 5, S. pneumoniae CCARM 4109; 6, S. pneumoniae CCARM 4112; 7, S. pneumoniae CCARM 4113; 8, S. pneumoniae CCARM 4114; 9, S. pneumoniae CCARM 4115; 10, S. pneumoniae CCARM 4003; 11, S. pneumoniae CCARM 4005; 12, S. pneumoniae CCARM 4078; 13, S. pneumoniae CCARM 4079; 14, S. Streptococcus and other bacterial (Lactococcus or Enterococcus) species are not shown because the results for these strains are the same as those seen in lanes 27-48; no S. pneumoniae-specific DNA is present. The arrow shows the expected PCR product of 353 bp common to all S. pneumoniae strains (lanes 1-26) .
gordonii (1/5 strains) and Streptococcus sanguinis, whilst one S. pneumoniae (1/26 strains) did not amplify with the lytA primers. In addition, 10 out of 21 Streptococcus anginosus strains produced amplicons of~800 bp using the Spn9828 primers, although they should have yielded amplified products of 227 bp. The false-positive results gave amplified PCR products from unexpected species or with different sizes. This was mainly caused by non-specific primers but sometimes also by a low annealing temperature. The results indicated that these previously described S. pneumoniaespecific primers can produce both false-positive and falsenegative results.
S. pseudopneumoniae is very closely related to S. pneumoniae. Pairwise comparisons show that their 16S rRNA gene sequences are almost identical, with a difference of only 5 bp between the two species, corresponding to 99.7 % identity. Consistent with this finding, a recent study demonstrated that the Spn9802 and ply primer sets could not differentiate S. pneumoniae and the recently acknowledged species S. pseudopneumoniae (Abdeldaim et al., 2008) . Surprisingly, the current cpsA-specific primer set differentiated S. pneumoniae from S. pseudopneumoniae. Thus, this primer set may be useful for discrimination of both species, as it is well known that S. pseudopneumoniae strains have no pneumococcal capsules, unlike S. pneumoniae (Keith et al., 2006) .
Recently, several real-time PCR assays have been developed for S. pneumoniae (Abdeldaim et al., 2008; Carvalho et al., 2007; Corless et al., 2001; Greiner et al., 2001; McAvin et al., 2001; Saukkoriipi et al., 2004) . Although these methods are sensitive, the results depend on the uniqueness of the applied probes. Among these, the most recent Spn9802-based real-time PCR assay gave positive results with S. pseudopneumoniae strains (CCUG 49455 T and CCUG 48465) and S. pneumoniae (Abdeldaim et al., 2008) . PCR with the cpsA-specific primer set efficiently detected genomic DNA purified from all 26 S. pneumoniae strains, and no other reference strain including two S. pseudopneumoniae strains was amplified. Therefore, the cpsA gene could be used as a new marker for detection of S. pneumoniae using a real-time detection assay. Because S. pneumoniae shares over 99 % 16S rRNA gene sequence identity with the other viridans group streptococci and because lateral gene transfer occurs among these species, the identification of novel genetic markers specific for S. pneumoniae is needed for accurate diagnosis and discrimination. Our findings suggest that the cpsAspecific primer set can discriminate S. pneumoniae from the closely related viridans group streptococci as well as other pneumococcus-like streptococci such as S. pseudopneumoniae. Moreover, the cpsA-specific primer set yielded maximal amplification at temperatures ranging from 53 to 63 u C as well as enhanced sensitivity compared with the previous Spn9802-and Spn9828-specific primers, implying a potential for novel multiplex or real-time PCR for the specific detection of S. pneumoniae.
In this study, SSH was used to identify the cpsA gene as a novel genomic marker specific for S. pneumoniae. The cpsAspecific primer set discriminated S. pneumoniae from other closely related viridans group members. This new primer set may be useful for the routine diagnosis and identification of presumptive S. pneumoniae isolates. Alternatively, the cpsA gene can be used as an additional genomic marker specific for S. pneumoniae in combination with previously described genetic markers such as lytA, ply, Spn9802 and Spn9828.
